참고문헌 (41)

1. 1 Guandalini S Probiotics for prevention and treatment of diarrhea J Clin Gastroenterol 2011 45 Suppl S149 S153 21992955 

2. 2 Issa I Moucari R Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol 2014 20 17788 17795 25548477 

3. 3 Guandalini S Cernat E Moscoso D Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children Benef Microbes 2015 6 209 217 25391345 

4. 4 Whelan K Quigley EM Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease Curr Opin Gastroenterol 2013 29 184 189 23286925 

   상세보기

5. 5 Yoon H Park YS Lee DH Seo JG Shin CM Kim N Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial J Clin Biochem Nutr 2015 57 129 134 26388670 

   상세보기

6. 6 Hou X Chen S Zhang Y Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China Clin Drug Investig 2014 34 783 793 

7. 7 Monnikes H Quality of life in patients with irritable bowel syndrome J Clin Gastroenterol 2011 45 Suppl S98 S101 21666428 

8. 8 Park JM Choi MG Kim YS Quality of life of patients with irritable bowel syndrome in Korea Qual Life Res 2009 18 435 446 19247807 

   상세보기

9. 9 Ma AD Kessler CM Al-Mondhiry HA Gut RZ Cooper DL Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study Blood Coagul Fibrinolysis 2016 27 753 760 26761583 

   상세보기

10. 10 Ishimoto H Oshima T Sei H Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients J Clin Biochem Nutr 2017 60 146 150 28366996 

    상세보기

11. 11 Belkind-Gerson J Tran K Di Lorenzo C Novel techniques to study colonic motor function in children Curr Gastroenterol Rep 2013 15 335 23852568 

    상세보기

12. 12 Biedermann L Rogler G The intestinal microbiota: its role in health and disease Eur J Pediatr 2015 174 151 167 25563215 

    상세보기

13. 13 Smits LP Bouter KE de Vos WM Borody TJ Nieuwdorp M Therapeutic potential of fecal microbiota transplantation Gastroenterology 2013 145 946 953 24018052 

14. 14 Kang JH Yun SI Park HO Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats J Microbiol 2010 48 712 714 21046354 

    원문보기 상세보기

15. 15 Kang JH Yun SI Park MH Park JH Jeong SY Park HO Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice PLoS One 2013 8 e54617 23382926 

    상세보기

16. 16 Jung SP Lee KM Kang JH Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial Korean J Fam Med 2013 34 80 89 23560206 

17. 17 Lee EH Kwon O Hahm KB Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation Health Qual Life Outcomes 2016 14 22 26882900 

18. 18 Rondanelli M Faliva MA Perna S Giacosa A Peroni G Castellazzi AM Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. Gut Microbes. 2017 . DOI: 10.1080/19490976.2017.1345414 

19. 19 Guyonnet D Chassany O Ducrotte P Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial Aliment Pharmacol Ther 2007 26 475 486 17635382 

20. 20 Lorenzo-Zúñiga V Llop E Suárez C I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life World J Gastroenterol 2014 20 8709 8716 25024629 

21. 21 Guglielmetti S Mora D Gschwender M Popp K Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study Aliment Pharmacol Ther 2011 33 1123 1132 21418261 

    상세보기

22. 22 Guandalini S Magazzù G Chiaro A VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study J Pediatr Gastroenterol Nutr 2010 51 24 30 20453678 

    상세보기

23. 23 O'Sullivan MA O'Morain CA Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study Dig Liver Dis 2000 32 294 301 11515626 

24. 24 Sen S Mullan MM Parker TJ Woolner JT Tarry SA Hunter JO Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome Dig Dis Sci 2002 47 2615 2620 12452404 

    상세보기

25. 25 Newcomer AD Park HS O'Brien PC McGill DB Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk Am J Clin Nutr 1983 38 257 263 6410897 

    상세보기

26. 26 Niv E Naftali T Hallak R Vaisman N The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study Clin Nutr 2005 24 925 931 16051399 

    상세보기

27. 27 Choi CH Jo SY Park HJ Chang SK Byeon JS Myung SJ A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life J Clin Gastroenterol 2011 45 679 683 21301358 

    상세보기

28. 28 Kabir MA Ishaque SM Ali MS Mahmuduzzaman M Hasan M Role of Saccharomyces boulardii in diarrhea predominant irritable bowel syndrome Mymensingh Med J 2011 20 397 401 21804501 

    상세보기

29. 29 Patel SM Stason WB Legedza A The placebo effect in irritable bowel syndrome trials: a meta-analysis Neurogastroenterol Motil 2005 17 332 340 15916620 

30. 30 Barbara G De Giorgio R Stanghellini V Cremon C Salvioli B Corinaldesi R New pathophysiological mechanisms in irritable bowel syndrome Aliment Pharmacol Ther 2004 20 Suppl 2 1 9 

31. 31 Corbett CL Thomas S Read NW Hobson N Bergman I Holdsworth CD Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndrome Gut 1981 22 836 840 7297914 

    상세보기

32. 32 Lu WZ Song GH Gwee KA Ho KY. The effects of melatonin on colonic transit time in normal controls and IBS patients Dig Dis Sci 2009 54 1087 1093 18720001 

33. 33 Horikawa Y Mieno H Inoue M Kajiyama G Gastrointestinal motility in patients with irritable bowel syndrome studied by using radiopaque markers Scand J Gastroenterol 1999 34 1190 1195 10636065 

    상세보기

34. 34 Lee OY Asian motility studies in irritable bowel syndrome J Neurogastroenterol Motil 2010 16 120 130 20535342 

35. 35 Kim HJ Vazquez Roque MI Camilleri M A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating Neurogastroenterol Motil 2005 17 687 696 16185307 

36. 36 Lee KN Lee OY Intestinal microbiota in pathophysiology and management of irritable bowel syndrome World J Gastroenterol 2014 20 8886 8897 25083061 

37. 37 Jeffery IB O'Toole PW Öhman L An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota Gut 2012 61 997 1006 22180058 

    상세보기

38. 38 Rajilić-Stojanović M Biagi E Heilig HG Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome Gastroenterology 2011 141 1792 1801 21820992 

39. 39 Krogius-Kurikka L Lyra A Malinen E Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers BMC Gastroenterol 2009 9 95 20015409 

40. 40 Yun SI Park HO Kang JH Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes J Appl Microbiol 2009 107 1681 1686 19457033 

    상세보기

41. 41 Bouchoucha M Nalpas B Berger M Cugnenc PH Barbier JP Recovery from disturbed colonic transit time after alcohol withdrawal Dis Colon Rectum 1991 34 111 114 1993406 

    상세보기